Target intelligence / Profile preview

Serotonin 5-hydroxytryptamine-3 receptor (5-HT3 receptor) (5-HT3 receptor)

Target
5-HT3 receptor
Molecular classification
Ion channel, Ligand-gated ion channel, Receptor, Cys-loop receptor family
01

Overview

The Serotonin 5-hydroxytryptamine-3 (5-HT3) receptor is a member of the Cys-loop family of ligand-gated ion channels, distinguishing it from all other serotonin receptors which are G protein-coupled receptors [1, 2]. It is a pentameric structure composed of various subunits (5-HT3A-E) that form a central pore permeable to cations like sodium, potassium, and calcium [1, 3]. These receptors are strategically located in the peripheral nervous system on vagal afferents and in the central nervous system within the area postrema and nucleus tractus solitarius, where they mediate the vomiting reflex [2, 4]. In the gut, 5-HT3 receptors regulate intestinal motility and fluid secretion, making them key players in the pathophysiology of irritable bowel syndrome [4, 5]. Pharmacological modulation of these receptors, primarily through competitive antagonism, is a cornerstone in the management of chemotherapy-induced and postoperative nausea and vomiting [2, 6]. Additionally, research suggests the receptor's involvement in sensory processing, anxiety, and cognitive functions, highlighting its potential as a target for diverse neuropsychiatric conditions [3, 5].

Other names
5-HT3R5-hydroxytryptamine receptor 3Serotonin-gated ion channelHTR3
02

Mechanism of action

Antagonism of the 5-HT3 receptor inhibits the activation of the vagus nerve and the chemoreceptor trigger zone, thereby preventing the emetic response and slowing colonic transit time.

03

Biological functions

Signal transductionNeurotransmissionFast excitatory synaptic transmissionRegulation of emesisGastrointestinal motility regulation
04

Disease associations

Chemotherapy-induced nausea and vomitingPostoperative nausea and vomitingIrritable bowel syndromeAnxietySchizophrenia
05

Safety considerations

QT interval prolongationConstipationHeadacheSerotonin syndromeIschemic colitis
06

Interacting drugs

Ondansetron

7 more in the full profile.

07

Biomarkers

HTR3A gene polymorphismsHTR3B gene polymorphisms

Beyond the preview

Go deeper on Serotonin 5-hydroxytryptamine-3 receptor (5-HT3 receptor) (5-HT3 receptor).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serotonin 5-hydroxytryptamine-3 receptor (5-HT3 receptor) (5-HT3 receptor).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call